CAN
IBB icon

Cetera Advisor Networks’s iShares Biotechnology ETF IBB Stock Holding History

Cetera Advisor Networks’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.61M Sell
40,909
-1,740
-4% -$238K 0.03% 581
2023
Q4 		$5.79M Sell
42,649
-20,420
-32% -$2.49M 0.03% 519
2023
Q3 		$7.71M Sell
63,069
-4,289
-6% -$545K 0.05% 376
2023
Q2 		$8.55M Sell
67,358
-12,618
-16% -$1.64M 0.06% 327
2023
Q1 		$10.3M Sell
79,976
-8,435
-10% -$1.1M 0.08% 282
2022
Q4 		$11.6M Buy
88,411
+17,978
+26% +$2.32M 0.09% 248
2022
Q3 		$8.24M Buy
70,433
+4,536
+7% +$563K 0.1% 228
2022
Q2 		$7.75M Buy
65,897
+2,975
+5% +$353K 0.1% 229
2022
Q1 		$8.2M Sell
62,922
-61,219
-49% -$7.97M 0.1% 216
2021
Q4 		$18.9M Buy
124,141
+27,012
+28% +$4.18M 0.23% 86
2021
Q3 		$15.7M Buy
97,129
+6,524
+7% +$1.1M 0.21% 102
2021
Q2 		$14.8M Buy
90,605
+11,431
+14% +$1.76M 0.21% 110
2021
Q1 		$11.9M Buy
79,174
+2,586
+3% +$411K 0.25% 102
2020
Q4 		$11.6M Buy
76,588
+16,967
+28% +$2.42M 0.27% 95
2020
Q3 		$8.07M Sell
59,621
-4,138
-6% -$561K 0.21% 115
2020
Q2 		$8.71M Buy
63,759
+5,777
+10% +$736K 0.23% 99
2020
Q1 		$6.25M Sell
57,982
-922
-2% -$106K 0.21% 108
2019
Q4 		$7.09M Buy
58,904
+292
+0.5% +$32.6K 0.19% 107
2019
Q3 		$5.83M Buy
58,612
+870
+2% +$91.1K 0.18% 118
2019
Q2 		$6.3M Buy
57,742
+199
+0.3% +$21.2K 0.19% 104
2019
Q1 		$6.43M Buy
57,543
+1,882
+3% +$206K 0.21% 101
2018
Q4 		$5.36M Sell
55,661
-1,608
-3% -$171K 0.21% 103
2018
Q3 		$6.98M Buy
57,269
+3,032
+6% +$357K 0.24% 86
2018
Q2 		$5.96M Buy
54,237
+407
+0.8% +$43.5K 0.3% 67
2018
Q1 		$5.76M Buy
53,830
+190
+0.4% +$21.1K 0.25% 88
2017
Q4 		$5.73M Sell
53,640
-696
-1% -$74.4K 0.24% 94
2017
Q3 		$6.04M Sell
54,336
-2,256
-4% -$241K 0.28% 85
2017
Q2 		$5.86M Buy
56,592
+3,969
+8% +$391K 0.28% 81
2017
Q1 		$5.14M Sell
52,623
-12
-0% -$1.15K 0.25% 94
2016
Q4 		$4.67M Sell
52,635
-12,057
-19% -$1.1M 0.24% 94
2016
Q3 		$6.24M Buy
64,692
+11,805
+22% +$1.12M 0.24% 100
2016
Q2 		$4.54M Sell
52,887
-60
-0.1% -$5.38K 0.26% 90
2016
Q1 		$4.61M Buy
52,947
+3,693
+7% +$330K 0.29% 79
2015
Q4 		$5.55M Buy
49,254
+5,322
+12% +$578K 0.35% 60
2015
Q3 		$4.46M Buy
43,932
+2,439
+6% +$293K 0.3% 71
2015
Q2 		$4.74M Hold
41,493
– – 0.3% 71
2015
Q1 		$4.74M Buy
41,493
+3,357
+9% +$370K 0.3% 70
2014
Q4 		$3.86M Sell
38,136
-666
-2% -$64.7K 0.27% 78
2014
Q3 		$3.54M Sell
38,802
-3,513
-8% -$308K 0.24% 86
2014
Q2 		$3.63M Buy
42,315
+3,111
+8% +$245K 0.24% 87
2014
Q1 		$3.09M Buy
39,204
+2,103
+6% +$175K 0.22% 104
2013
Q4 		$2.81M Buy
37,101
+13,878
+60% +$985K 0.21% 100
2013
Q3 		$1.62M Buy
23,223
+255
+1% +$16.7K 0.14% 154
2013
Q2 		$1.33M Buy
+22,968
New +$1.33M 0.13% 164

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Cetera Advisor Networks's IBB Position: Q1 2024 in Review

Cetera Advisor Networks reduced its iShares Biotechnology ETF (IBB) stake by 4.1% in Q1 2024, selling an estimated $238K and leaving 40,909 shares worth $5.61M. The position accounts for 0.03% of the portfolio, ranked #581.

Cetera Advisor Networks first reported a position in IBB in Q2 2013 and has held it in 44 quarters since. The position peaked at $18.9M in Q4 2021. 901 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Cetera Advisor Networks held 40,909 shares of iShares Biotechnology ETF worth $5.61M as of Q1 2024.
  • Cetera Advisor Networks sold 1,740 iShares Biotechnology ETF shares in Q1 2024, an estimated $238K.
  • iShares Biotechnology ETF made up 0.03% of Cetera Advisor Networks's portfolio in Q1 2024, its #581 holding.
  • Cetera Advisor Networks first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 44 quarters since.
  • Cetera Advisor Networks's iShares Biotechnology ETF position peaked at $18.9M in Q4 2021.
  • 901 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.